Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Roche's Oral SERD gives more confidence to Breast Cancer
Date 16 December 2025

Roche's Oral SERD gives more confidence to Breast Cancer

Announcement Roche, a leading multinational healthcare giant drug investigation and efforts for early stage breast cancer has finally showed progress. Roche’s oral SERD reduced death risk by 3...

Amylyx's confident data from its First-in-human LUMINA Trial
Date 10 December 2025

Amylyx's confident data from its First-in-human LUMINA Trial

Announcement Amylyx Pharmaceuticals, Inc., a leading company, has showcased the presentation of early tolerability and safety data from the combined of results from the running work characterizing b...

Microbiome Labs' new formula, a relief for digestive issues
Date 08 December 2025

Microbiome Labs' new formula, a relief for digestive issues

Announcement Microbiome Labs, a champion in microbiome-related solutions, inaugurated DigestMate™, a probiotic and 2-in-1 digestive enzyme formula. As observed, the digestive health issues have...

Capricor returns to the FDA's doorstep for DMD Cardiomyopathy Therapy
Date 08 December 2025

Capricor returns to the FDA's doorstep for DMD Cardiomyopathy Therapy

Announcement Capricor has again come up with the pivotal results for DMD cardiomyopathy therapy after the rejection. After six months of receiving the shocking rejection for Capricor’s cell th...

FDA approved enGene's solution to participate in the CMC and CDRP program
Date 05 December 2025

FDA approved enGene's solution to participate in the CMC and CDRP program

Announcement enGene Holdings Inc., a known clinical level non-viral genetic medicines company, proudly declared its detalimogene voraplasmid selection by the FDA for its Pilot program to contribute t...

tiakis Biotech finalised its data package to invest in the clinical trial for PAH
Date 05 December 2025

tiakis Biotech finalised its data package to invest in the clinical trial for PAH

Announcement tiakis Biotech AG, a leading clinical-level biopharmaceutical company conquering novel therapeutics for cardiovascular and life-threatening pulmonary disease, confirmed the completion o...

Cleveland's IsoPSA® IVD kit received FDA approval
Date 04 December 2025

Cleveland's IsoPSA® IVD kit received FDA approval

Announcement Cleveland Diagnostics, Inc., an advanced commercial-level precision oncology company, proudly shared its FDA approval news for its IsoPSA® in vitro diagnostic (IVD) kit via the Prema...

Cardiol showcased impressive data from its ARCHER study
Date 04 December 2025

Cardiol showcased impressive data from its ARCHER study

Announcement Cardiol Therapeutics Inc., a clinical-level life sciences company known for modernising the anti-fibrotic and anti-inflammatory therapies for heart conditions, has released its strong an...

Gan & Lee's new blockbuster GRADUAL-3 Clinical Study to fix weight management
Date 02 December 2025

Gan & Lee's new blockbuster GRADUAL-3 Clinical Study to fix weight management

Announcement Gan & Lee Pharmaceuticals is now entering its third large-scale phase 3 clinical study, GRADUAL-3, of its glucagon-like peptide-1 receptor agonist (GLP-1 RA) bofanglutide injection ...

Hemostemix plans to kickstart its first two Cardiology Practices via an acquisition strategy
Date 01 December 2025

Hemostemix plans to kickstart its first two Cardiology Practices via an acquisition strategy

Announcement Hemostemix Inc. is delighted to read out the bond letter of its plant for beginning with the first two cardiology practices via acquisition strategy, inspired by the Company’s int...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.